ProKidney Corp.
PROK
$2.28
$0.031.37%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.81% | -3.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.81% | -3.91% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -1.81% | -3.91% | |||
| SG&A Expenses | -17.30% | -2.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.74% | -4.06% | |||
| Operating Income | 3.75% | 4.06% | |||
| Income Before Tax | 2.31% | 3.33% | |||
| Income Tax Expenses | -33.96% | 43.49% | |||
| Earnings from Continuing Operations | 3.04% | 2.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -5.09% | -3.79% | |||
| Net Income | 0.50% | 1.09% | |||
| EBIT | 3.75% | 4.06% | |||
| EBITDA | 4.43% | 3.88% | |||
| EPS Basic | 3.63% | 2.39% | |||
| Normalized Basic EPS | -11.52% | 0.00% | |||
| EPS Diluted | 3.63% | 2.39% | |||
| Normalized Diluted EPS | -11.52% | 0.00% | |||
| Average Basic Shares Outstanding | 3.26% | 1.36% | |||
| Average Diluted Shares Outstanding | 3.26% | 1.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||